Hepatic Oncology

Scope & Guideline

Elevating Research on Hepatic Malignancies

Introduction

Delve into the academic richness of Hepatic Oncology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2045-0923
PublisherFUTURE MEDICINE LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Converge2016, 2020, from 2022 to 2023
AbbreviationHEPAT ONCOL / Hepat. Oncol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND

Aims and Scopes

The journal 'Hepatic Oncology' primarily focuses on the comprehensive understanding and treatment of liver cancers, with an emphasis on hepatocellular carcinoma (HCC) and its related conditions. It aims to publish innovative research that addresses clinical, therapeutic, and pathological aspects of hepatic malignancies.
  1. Clinical Management of Hepatocellular Carcinoma (HCC):
    The journal emphasizes research on the management strategies for HCC, including diagnosis, treatment patterns, and patient outcomes in various clinical settings.
  2. Innovative Treatment Approaches:
    A core focus is on novel therapeutic modalities such as immunotherapy, locoregional therapies, and systemic treatments, exploring their efficacy and safety in treating liver cancer.
  3. Real-World Evidence and Patient Journeys:
    Research that utilizes real-world data to understand the treatment journey of patients with liver cancer, contributing to evidence-based practice and improving patient care.
  4. Pathophysiology and Biomarkers:
    Investigations into the underlying mechanisms of liver cancer, including the identification of biomarkers for diagnosis and prognosis, are central to the journal's contributions.
  5. Health Economics and Outcomes Research:
    The journal includes analyses on the economic burden of liver cancer treatments and the healthcare patterns associated with managing these patients.
Recent publications in 'Hepatic Oncology' indicate a dynamic shift towards several trending and emerging themes that reflect the evolving landscape of liver cancer research and treatment.
  1. Immunotherapy and Combination Treatments:
    There is a notable increase in research exploring the role of immunotherapy in liver cancer, particularly in combination with other treatments, highlighting its potential to improve survival outcomes.
  2. Real-World Data Utilization:
    Recent studies focus on leveraging real-world data to assess treatment journeys and outcomes, providing valuable insights that complement clinical trial findings.
  3. Advanced Imaging Techniques:
    Emerging themes around advanced imaging methods for assessing treatment efficacy and liver cancer progression are gaining attention, reflecting the need for improved diagnostic tools.
  4. Personalized Medicine Approaches:
    The trend towards personalized medicine is evident, with a growing interest in tumor mutational burden and biomarkers to tailor treatments for individual patients.
  5. Economic Impact Studies:
    Research examining the economic burden of liver cancer treatments and healthcare resource utilization is increasingly featured, emphasizing the importance of health economics in clinical decision-making.

Declining or Waning

While 'Hepatic Oncology' continues to explore various facets of liver cancer research, certain themes have seen a decline in publication frequency or relevance. These waning themes may reflect shifts in research focus or advancements in treatment options.
  1. Efficacy of Traditional Chemotherapy:
    There appears to be a reduction in studies focusing solely on traditional chemotherapy regimens for liver cancer, as newer targeted and immunotherapeutic options gain prominence.
  2. Historical Perspectives on HCC Treatment:
    Papers providing historical context or retrospective analyses of older treatment methodologies are becoming less frequent, likely overshadowed by contemporary research and innovative therapies.
  3. Basic Science Studies on Hepatic Tumor Biology:
    Research focusing exclusively on basic science aspects of liver tumor biology without direct clinical implications is becoming less prevalent, as the journal shifts towards more clinically relevant studies.

Similar Journals

Journal of Clinical and Experimental Hepatology

Transforming insights into impactful liver care.
Publisher: ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTDISSN: 0973-6883Frequency: 4 issues/year

The Journal of Clinical and Experimental Hepatology, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a premier platform dedicated to advancing the field of hepatology. With an ISSN of 0973-6883 and an E-ISSN of 2213-3453, this journal has gained recognition for its impactful contributions to both clinical practice and scientific research in the domain of liver health. Ranking in the Q2 quartile for Hepatology in 2023 and positioned at 33rd out of 82 in Scopus’s Hepatology category, it reflects a robust impact factor and a commitment to publishing high-quality, peer-reviewed articles. Researchers, clinicians, and students can engage with a wealth of open-access content covering the latest advancements, challenges, and insights in hepatology, as the journal aims to disseminate knowledge from 2011 through 2025. Join the community of experts as we explore critical developments in the understanding and treatment of liver diseases.

HEPATOLOGY RESEARCH

Pioneering studies that transform the landscape of Hepatology.
Publisher: WILEYISSN: 1386-6346Frequency: 12 issues/year

Hepatology Research, ISSN 1386-6346 and E-ISSN 1872-034X, is a premier academic journal published by Wiley that serves the dynamic fields of Hepatology and Infectious Diseases. With an impressive 2023 impact factor and ranked Q2 in Hepatology and Q1 in Infectious Diseases, this journal stands out as a vital resource for researchers, professionals, and students. Covering a broad spectrum of topics related to liver health, the journal aims to disseminate cutting-edge research and insights from the converged years of 1997 to 2024. As an open-access platform, it fosters the global sharing of knowledge, providing valuable access to pioneering studies that address pressing issues in liver disease and its associated infections. Based in the United Kingdom, at 111 River St, Hoboken, NJ, Hepatology Research is pivotal for advancing scientific understanding and improving patient outcomes worldwide.

Journal of Clinical and Translational Hepatology

Exploring the frontiers of liver disease and treatment.
Publisher: XIA & HE PUBLISHING INCISSN: 2225-0719Frequency: 12 issues/year

Journal of Clinical and Translational Hepatology is an esteemed publication dedicated to advancing the field of hepatology through innovative research and clinical insights. Published by XIA & HE PUBLISHING INC, this journal connects researchers and healthcare professionals in the exploration of liver diseases and their management. With an impact factor that reflects its significant contribution to the discipline, the Journal holds a commendable Q2 classification in Hepatology as of 2023, and it ranks highly in both Gastroenterology and Hepatology categories on Scopus, positioning it within the top 80th percentile of its field. Although the journal is not open access, it provides its audience with invaluable information, encouraging collaboration that aims to translate clinical findings into transformative patient care. With a publication history spanning from 2013 to 2024, the Journal of Clinical and Translational Hepatology has established itself as a vital resource for researchers, clinicians, and students alike, making it a prominent voice in the hepatological community.

LIVER INTERNATIONAL

Innovating liver research for a healthier tomorrow.
Publisher: WILEYISSN: 1478-3223Frequency: 12 issues/year

LIVER INTERNATIONAL, with its ISSN 1478-3223 and E-ISSN 1478-3231, is a prestigious peer-reviewed journal published by Wiley in the United Kingdom. Established in 2003, it focuses on advancing the field of hepatology, covering a broad spectrum of topics including liver disease, hepatocellular carcinoma, and transplantation. Ranking #10 out of 82 in the Scopus category for Medicine - Hepatology and boasting a remarkable 88th percentile, LIVER INTERNATIONAL has secured its reputation as a leading journal, recognized as Q1 in the 2023 category quartiles. The journal emphasizes accessibility, offering an open access option to ensure that critical research findings reach a wider audience. By facilitating the dissemination of high-quality research, LIVER INTERNATIONAL plays a vital role in shaping contemporary hepatological discourse and bridging academic inquiry with clinical practice, making it an essential resource for researchers, healthcare professionals, and students alike.

Future Oncology

Unveiling groundbreaking findings in oncology.
Publisher: FUTURE MEDICINE LTDISSN: 1479-6694Frequency: 40 issues/year

Future Oncology is a premier peer-reviewed journal published by FUTURE MEDICINE LTD, dedicated to advancing research and innovation within the field of oncology. Established in 2005 and set to continue through 2024, this journal serves as an essential resource for researchers, healthcare professionals, and students engaged in cancer studies. With its emphasis on groundbreaking findings and multidisciplinary approaches, Future Oncology holds an esteemed reputation, reflected in its 2023 category quartiles ranking it in Q2 for Cancer Research and Q1 for Medicine (miscellaneous). The journal is indexed in Scopus, showcasing its rigorous content, with rankings in the 63rd percentile for Oncology and the 46th percentile for Cancer Research. Although it does not operate on an open-access model, its commitment to disseminating cutting-edge findings makes it an invaluable asset for those seeking to stay at the forefront of oncology research.Future Oncology strives to bridge the gap between laboratory and clinical research, fostering collaboration and appreciation for the complexities of cancer treatment.

Translational Oncology

Advancing Cancer Research from Lab to Life
Publisher: ELSEVIER SCIENCE INCISSN: 1936-5233Frequency: 6 issues/year

Translational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.

Therapeutic Advances in Gastroenterology

Championing the future of gastroenterology.
Publisher: SAGE PUBLICATIONS LTDISSN: 1756-283XFrequency: 1 issue/year

Therapeutic Advances in Gastroenterology, published by SAGE Publications Ltd, is a premier open access journal dedicated to the advancement of knowledge in the field of gastroenterology. Since its inception in 2008 and its transition to open access in 2018, the journal has consistently provided high-quality peer-reviewed research articles, review papers, and clinical studies that address the latest therapeutic advancements and challenges in gastrointestinal medicine. With an impressive impact factor and a 2023 Scopus ranking placing it in the Q1 quartile of gastroenterology journals, it stands as a leading platform for researchers, clinicians, and healthcare professionals. The journal’s commitment to disseminating impactful research has positioned it at the forefront of academic discourse, offering a vital resource for those devoted to improving patient outcomes in digestive health. The United Kingdom-based journal invites submissions that contribute to the understanding and treatment of gastrointestinal disorders, ensuring that cutting-edge findings reach a global audience.

Clinical and Experimental Hepatology

Unlocking the Potential of Hepatological Research
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 2392-1099Frequency: 4 issues/year

Clinical and Experimental Hepatology is a pivotal journal dedicated to advancing the field of hepatology, providing a platform for researchers, clinicians, and students to disseminate and explore groundbreaking findings. Published by TERMEDIA PUBLISHING HOUSE LTD in Poland, this journal serves as a vital resource for professionals seeking to enhance their knowledge and contributions in the realm of liver diseases and their management. With an impact factor reflective of its growing influence—ranking Q3 in Hepatology for the year 2023 and holding the 49th position out of 82 in Scopus Medicine Hepatology ranks—this publication underscores the significance of innovative research in this specialized domain. While it currently operates through a subscription model rather than open access, it bridges the gap in hepatological literature by featuring a diverse array of scholarly articles, case reports, and reviews from 2015 to 2024. Researchers and health professionals alike will find valuable insights that can enhance clinical practice and inform future studies, solidifying its importance in the hepatology community.

World Journal of Hepatology

Leading the way in hepatology research and education.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1948-5182Frequency: 12 issues/year

World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.

Gastroenterologia y Hepatologia

Fostering innovation in the diagnosis and treatment of liver diseases.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.